Skip to the rundown
GetYourBrief
Search

Rundown · Monday, July 20, 2026

Biotech news on July 20, 2026

On Monday, July 20, 2026 the Biotech desk recorded 6 news events. The earliest report came from finanznachrichten.de at 05:30 UTC. One more event was reported; it is listed at the end.

  1. 02

    India approves first dengue vaccine QDENGA after DCGI clearance

    2 outlets · first: dailymirror.lk Fda approval

    Machine summary India has approved its first dengue vaccine, QDENGA, after clearance from the DCGI, according to reports from thenorthlines.com and dailymirror.lk.

    1. India approved its first dengue vaccine, QDENGA, according to thenorthlines.com.
    2. The approval followed DCGI clearance, thenorthlines.com reported.
    3. dailymirror.lk reported that India approved its first dengue vaccine QDENGA after DCGI clearance.

    Reported by dailymirror.lk and thenorthlines.com.

    • Drug Controller General of India (DCGI)
    • QDENGA (TAK-003)
  2. 03

    Medtrum reports progress toward German launch of 300U patch pump

    2 outlets · first: Pr Newswire Pharma Mostly press releases

    Reported by Pr Newswire and manilatimes.net.

    • TouchCare Nano System
    • Medtrum
    • 300U Tubeless Patch Pump
    • DDG 2026

    Full coverage: every report, when each was published, and who was named (2 outlets)

  3. 04

    Coverage recordmontrealgazette.com: “Galderma Launches Alastin® in Japan and Key Markets Across Asia Pacific, Expanding Its Footprint in the Region”

    2 outlets · first: finanznachrichten.de Pharma Mostly press releases

    Reports ran between 05:30 and 06:00 UTC on Jul 20.

    The outlets that reported this event are listed with links to their reports; no summary of ours passed our automated checks for it, which says nothing about the event (how they work).

    Reported by finanznachrichten.de and montrealgazette.com.

    • Galderma
    • Alastin
  4. 05

    Moderna stock up 109% in 2026; Cramer comments on Moderna stock

    1 outlet · first: fool.com

    Machine summary Key facts from the reports:

    1. Moderna stock has climbed 109% in 2026, the report said.

    Reported by fool.com.

  5. 06

    Regentis receives Japanese patent allowance

    1 outlet · first: torontotelegraph.com (Big News Network)

    Machine summary Regentis said it received a Japanese patent allowance covering a proprietary manufacturing technology, which it said strengthens its global GelrinC intellectual property portfolio.

    1. Regentis said it received a Japanese patent allowance.
    2. Regentis said the allowance covers a new proprietary manufacturing technology.
    3. Regentis said the allowance strengthens its global GelrinC intellectual property portfolio.

    Reported by torontotelegraph.com (Big News Network), tennesseedaily.com (Big News Network) and newjerseytelegraph.com (Big News Network).

    • GelrinC

More events reported

No summary of ours and no outlet headline passed our automated checks for these, which says nothing about the events (how they work); the outlets and their reports are linked.

  1. · 1 outlettechcrunch.comNamed in the reports: Colossal Biosciences

Each summary and its key facts are a machine summary of the reports linked under it; the outlets, times and counts come from those reports' own records. How a rundown is built.

Also covered for this desk

1 event homed on another desk that the Biotech desk also carried on July 20, 2026.

The days around it

Sources: the outlets' reports linked on this page; counts and times from GetYourBrief's record of those reports (methodology).